Browsing Tag
FDA
341 posts
LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection
Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus…
January 1, 2020
CooperVision MiSight contact lens gets FDA approval to slow down myopia in children
Soft contact lens manufacturer CooperVision has secured approval for its MiSight contact lens from the US Food and…
November 16, 2019
Alcon launches AcrySof IQ PanOptix trifocal intraocular lens for cataract surgery patients in US
Alcon, a leading global eye care company, has introduced its AcrySof IQ PanOptix trifocal intraocular lens (IOL) in…
October 13, 2019
Novartis bags Beovu FDA approval for wet AMD
Beovu FDA approval for wet AMD : Swiss pharma giant Novartis has been given approval from the US…
October 9, 2019
ProTom Radiance 330 proton therapy system bags FDA 510(k) Clearance
ProTom International has been given 510(k) clearance from the US Food and Drug Administration (FDA) for its Radiance…
October 8, 2019
Vitruvias Therapeutics and Sinotherapeutics team up to launch bioequivalent Rythmol SR in US
Vitruvias Therapeutics, a US-based finished-dose generic drug manufacturer, has announced the US launch of a bioequivalent, FDA-approved version…
March 9, 2019
Novartis secures FDA approval for Egaten as fascioliasis treatment
Novartis has achieved a significant milestone with the FDA’s approval of Egaten (triclabendazole) for the treatment of fascioliasis…
March 2, 2019
Alexion Pharmaceuticals secures FDA priority review for SOLIRIS in neuromyelitis optica spectrum disorder
Alexion Pharmaceuticals has secured a significant milestone with the FDA granting priority review for its C5 complement inhibitor,…
February 23, 2019
EC approves ADCETRIS for treating CD30+ Stage IV Hodgkin lymphoma
The European Commission (EC) has officially expanded the approval of Takeda Pharmaceutical’s ADCETRIS (brentuximab vedotin) to include the…
February 11, 2019
Samsung Bioepis partners with C-Bridge Capital to expand biosimilar portfolio in China
Samsung Bioepis, a South Korean leader in biopharmaceuticals, has struck a deal with private equity firm C-Bridge Capital…
February 11, 2019